Ladenburg Thalmann Financial Services’s Juniper Pharmaceuticals, Inc. Common Stock JNP Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio JNP Stock Details JNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-25	Closed	–	–	4905
2015 Q4	$0	Buy	+25	New	+$290	﹤0.01%	4863
2014 Q4	–	Sell	-80	Closed	–	–	4504
2014 Q3	$0	Hold	80	–	–	﹤0.01%	4108
2014 Q2	$1K	Hold	80	–	–	﹤0.01%	3824
2014 Q1	$1K	Buy	+80	New	+$553	﹤0.01%	3684
2013 Q4	–	Sell	-50	Closed	–	–	3917
2013 Q3	$0	Buy	+50	New	+$337	﹤0.01%	3895

Other funds holding JNP

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JAM

JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Ladenburg Thalmann Financial Services's JNP Position: Q1 2016 in Review

Ladenburg Thalmann Financial Services sold out of Juniper Pharmaceuticals, Inc. Common Stock (JNP) in Q1 2016, closing a stake of 25 shares.

Ladenburg Thalmann Financial Services first reported a position in JNP in Q3 2013 and held it in 5 quarters. The position peaked at $1K in Q2 2014. 50 funds tracked by Wall St. Rank hold JNP as of Q1 2016.

Ladenburg Thalmann Financial Services reported no remaining Juniper Pharmaceuticals, Inc. Common Stock position as of Q1 2016 after selling out during the quarter.
Ladenburg Thalmann Financial Services sold 25 Juniper Pharmaceuticals, Inc. Common Stock shares in Q1 2016.
Ladenburg Thalmann Financial Services first reported a position in Juniper Pharmaceuticals, Inc. Common Stock in Q3 2013 and held it in 5 quarters.
Ladenburg Thalmann Financial Services's Juniper Pharmaceuticals, Inc. Common Stock position peaked at $1K in Q2 2014.
50 funds tracked by Wall St. Rank held Juniper Pharmaceuticals, Inc. Common Stock as of Q1 2016.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q1 2016, filed 16 May 2016.